StockWatch
·

Parmax Pharma Ltd Q1 FY27 Results

PARMAXQ1 FY27 Results
Filing
Result:Very Good· Market: Up#Turnaround#Broad based
MetricValue ( Cr)Q1 FY26
Revenue8.22323.3%
Total Income10.30428.5%
Expenditure8.10198.5%
PBT2.20387.7%
Net Profit2.20387.7%
OPM10.08%22.95pp
NPM21.35%60.58pp
EPS5.88188.2%
View full financials

Adjusted for a small base, this is a clean loss-to-profit turnaround with revenue up 323% YoY and OPM swinging from -12.9% to +10.1%, showing genuine core-business improvement rather than a one-off gain.

Informational and educational content only. Not investment advice.